Skip to content

Showing the single result

GFAP antibodies

9024rabbitmonoclonalIgG2bhuman mouse ratWBICCIHC

Glial Fibrillary Acidic Protein (GFAP) has become a fundamental target of investigation in scientific research, particularly in the realm of neuroscience and neurobiology. As an intermediate filament protein predominantly expressed in astrocytes, GFAP serves as a crucial cell marker for proliferating cells, especially in the context of brain and spinal cord studies. Due to its specific expression in activated astrocytes, a hallmark of many neurological disorders and injuries, GFAP has been extensively employed as an immunohistochemical marker to identify and quantify proliferating astrocytes and glial cells. This valuable marker has been instrumental in uncovering the underlying mechanisms of gliogenesis, neuroinflammation, and tissue repair after brain injuries or diseases. Its utility in identifying proliferating cells in the nervous system has significantly advanced our understanding of neuroregeneration and holds great promise for developing novel therapeutic approaches to combat neurological disorders and promote neural repair and recovery.